Contrast-induced nephropathy in 2010

Applied Radiology

Volumn 39, Issue 9, 2010, Pages 20-22

  Katzberg, Richard W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; CREATININE; IOHEXOL; THEOPHYLLINE; VASODILATOR AGENT;

COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HUMAN; KIDNEY DISEASE; RISK FACTOR; SHORT SURVEY;

EID: 77956955263     PISSN: 01609963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (22)

1. Latest IMV CT census shows slow-down in the purchase of CT technology. IMV Medical Information Division, Inc. 2008. Available online: http://www. imvinfo.com/user/documents/content-documents/def-dis/2008-03-21-11-25-43-706. pdf. Accessed August 11, 2010.
2. Katzberg RW. Urography into the 21st century: New contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology. 1997;204: 297-312.
3. Bellomo R, Kellum J, Ronco C. Acute renal failure: Time for consensus. Intensive Care Med. 2001;27: 1685-1688.
4. Byrd L, Sherman RL. Radiocontrast-induced acute renal failure: A clinical and pathophysiologic review. Medicine. 1979;58:270-279.
5. Tepel M, van der Geit M, Schwarzfeld C, et al. Prevention of radiographic contrast-agent-induced reductions in renal function by acetyleysteine. N Engl J Med. 2000;343:180-184.
6. Becker CR, Reiser MF. Use of iso-osmolar nonionic dimeric contrast media in multidetector row computed tomography angiography for patients with renal impairment. Invest Radiol. 2005;40:672-675.
7. Barrett BJ, Katzberg RW, Thomsen HS, et al. Contrast- induced nephropathy in patients with chronic kidney disease undergoing computed tomography. A double blind comparison of iodixanol and opamidol. Invest Radiol. 2006;41:815-821.
8. Thomsen HS, Marcos SK, Erley CM, et al. The ACTIVE trial: Comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol. 2008;43:170-178.
9. Kuhn MJ, Chen N, Sahani DV, et al. The PREDICT study: A randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. Am J Roentgenol. 2008;191:151-157.
10. Nguyen SA, Suranyi P, Ravenel JG, et al. Isoosmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: Effect on kidney function. Radiology. 2008;248:97-105.
11. Weisbord SD, Mor MK, Resnick AL, et al. Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol. 2008;3:1274-1281.
12. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995;47:254-261.
13. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000;36:1542-1548.
14. Solomon R. Contrast-induced acute kidney injury (CIAKI). Radiol Clin N Am. 2009;47:783-788.
15. Ellis JH, Cohan RH. Reducing the risk of contrastinduced nephropathy: A perspective on the controversies. AJR Am J Roentgenol. 2009;192:1544-1549.
16. Cramer BC, Parfrey PS, Hutchinson TA, et al. Renal function following infusion of radiologic contrast material: A prospective controlled study. Arch Intern Med. 1985;145:87-89.
17. Heller CA, Knapp J, Halliday J, et al. Failure to demonstrate nephrotoxicity. Med J Aust. 1991;155: 329-332.
18. Newhouse JH, Kho D, Rao QA, Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: Implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol. 2008;191:376-382.
19. Bruce RJ, Djamali A, Shinki K, et al. Background fluctuation of kidney function versus contrastinduced nephrotoxicity. AJR Am J Roentgenol. 2009;192:711-718.
20. Katzberg RW, Barrett BJ. Risk of iodinated contrast material-induced nephropathy with intravenous administration. Radiology. 2007;243:622-628. Epub 2007 Apr 19.
21. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130:461-470.
22. American College of Radiology Manual on Contrast Media, version 6.0. Version 7.0 available online at: http://www.acr.org/SecondaryMainMenuCategories/ quality-safety/contrast-manual.aspx. Accessed August 11, 2010.